Pharmaceutical Executive
In this demanding environment, yesterday’s product launch playbook can no longer be relied upon to yield the expected patient or business outcomes, writes Boris Bogdan.
Boris Bogdan, M.D
Advertisement
Articles by Boris Bogdan, M.D
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Foundayo Under National Priority Voucher Program
2
Trump Administration’s Leadership Carousel Across Key Agencies
3
The New Antitrust Era: Why CVS-Style Healthcare Integration is Now the FTC’s Primary Target
4
More Than Just Pricing: MFN’s Impact on Pharma: Q&A with Lindsay Bealor Greenleaf
5